AOD-9604 Peptide Therapy for Healthy Fat Metabolism Support
A clinician-guided peptide program designed to support healthy fat-metabolism pathways and body-composition goals—best used alongside nutrition, movement, sleep, and consistency.
Prescription-only therapy. Treatment is provided only if a licensed clinician determines it is appropriate based on your medical history, current medications, and goals. Use only as prescribed. Individual results vary.
See How It Works
Licensed clinician review + safety screening
Licensed pharmacy fulfillment + discreet shipping
Transparent 4-week pricing (no subscription required)
Available in eligible states.
Choose your AOD-9604 plan
- Dosage Description
- 200mg SQ once daily for 4 weeks
- Dose
- 200
- Duration
- 4 Week
- Package Size
- 5
- Form
- Injection
- Dosage Description
- 250mg SQ once daily for 4 weeks
- Dose
- 250
- Duration
- 4 Week
- Package Size
- 5
- Form
- Injection
- Dosage Description
- 300mcg SQ once daily for 4 weeks
- Dose
- 300
- Duration
- 4 Week
- Package Size
- 5
- Form
- Injection
- Dosage Description
- 350mcg SQ once daily for 4 weeks
- Dose
- 350
- Duration
- 4 Week
- Package Size
- 5
- Form
- Injection
- Dosage Description
- 400mcg SQ once daily for 4 weeks
- Dose
- 400
- Duration
- 4 Week
- Package Size
- 5
- Form
- Injection
- Dosage Description
- 500mcg SQ once daily for 4 weeks
- Dose
- 400
- Duration
- 4 Week
- Package Size
- 5
- Form
- Injection
AOD-9604 Peptide: How It Supports Fat-Metabolism Signaling
AOD-9604 is a synthetic peptide fragment originally researched for its potential role in fat-metabolism signaling. It’s often discussed in “body composition” programs because it may support how the body mobilizes and utilizes stored fat—without positioning it as a stimulant or a shortcut.
Who AOD-9604 may be best for
AOD-9604 may be considered for adults who:
- Are already working on nutrition and activity, but want additional support for body-composition goals
- Prefer a non-stimulant approach and want clinician oversight
- Want transparent 4-week pricing and discreet delivery
- Understand outcomes vary and are not guaranteed
Who may not be a candidate
Your clinician may advise against AOD-9604 (or require additional review) if you:
- Are pregnant, trying to become pregnant, or breastfeeding
- Have active cancer, a recent cancer history, or an unexplained mass (requires careful clinician review)
- Have significant endocrine disorders or unexplained hormone abnormalities (requires evaluation)
- Have uncontrolled diabetes or significant blood sugar instability (clinician review required)
- Have significant liver or kidney disease (clinician review required)
- Have a history of severe allergic reactions to injectable therapies or formulation components
- Compete in tested sports (may be prohibited under anti-doping rules)
What you get with StemVera’s AOD-9604 program
Included:
- Secure online intake (goals, symptoms, medical history, medications, allergies)
- Licensed clinician review to confirm eligibility and safety
- Prescription only if appropriate
- Pharmacy fulfillment + discreet delivery
- Supplies included as needed for administration
- Ongoing check-ins via secure messaging for questions and tolerance support
How to start AOD-9604
- 1
Complete your intake
Share your goals, timeline, current routine, and full medical history.
- 2
Clinician review
A licensed clinician screens for risks, reviews medications/supplements, and confirms whether AOD-9604 is appropriate.
- 3
Discreet delivery
If prescribed, your plan ships discreetly with tracking.
- 4
Ongoing support
Message your care team for questions, side effects, or health changes. Use only as prescribed.
Injection basics (what to expect)
No dosing, timing, titration, or technique instructions here—follow your prescription label and clinician guidance exactly. Use only as prescribed.
- Many peptide plans are administered as an under-the-skin injection when prescribed
- Mild injection-site redness, soreness, or bruising can occur
- Never share medication or supplies
- If anything is unclear, message your care team before continuing
Timeline: realistic expectations
Most people evaluate fat-metabolism and body-composition support over several weeks, not days.
- What some people report (varies):
- Early: subtle shifts in cravings, routine consistency, or energy patterns
- Over time: gradual changes in measurements and body composition when paired with consistent lifestyle habits
- Best outcomes: with protein-forward nutrition, strength training, sleep hygiene, hydration, and stress management
- Results vary widely. No therapy can guarantee fat loss, “spot reduction,” or a specific change on the scale.
Possible side effects
Common (often mild)
- Injection-site redness, swelling, tenderness, or itching
- Headache
- Nausea or stomach discomfort
- Fatigue or lightheadedness
Less common but serious (seek medical help)
- Signs of allergic reaction (hives, facial swelling, trouble breathing)
- Injection-site infection (worsening redness, warmth, pus, fever)
- Severe dizziness/fainting, chest pain, or rapid heart rate
- New or worsening symptoms that concern you
If side effects feel severe, sudden, or persistent, stop and contact your care team promptly.
Safety + important warnings
- AOD-9604 is not appropriate for everyone. Your clinician will review your history, medications, and risk factors before prescribing.
- Important considerations:
- Limited human data: evidence and long-term safety data are limited; risks may not be fully known
- Quality and immunogenicity risk: peptide therapies require high-quality manufacturing and handling; immune reactions can occur
- Not for pregnancy/breastfeeding: avoid if pregnant, trying to conceive, or breastfeeding
- Cancer history needs caution: disclose any past or current malignancy for clinician review
- Glucose and metabolic conditions: disclose diabetes/prediabetes and all glucose-lowering medications
- Tested athletes: verify anti-doping rules if applicable
- Use only as prescribed; do not self-adjust or mix with non-prescribed products
- Compounded products are not FDA-approved and do not undergo FDA premarket review for safety, effectiveness, or quality. These therapies may be prescribed for off-label use; results vary
Compare weight management + peptide options
Semaglutide Injection
GLP-1 option focused on appetite control and weight management support (provider-directed).
Tirzepatide Injection
Dual-pathway option for eligible patients focused on weight management support (provider-directed).
Tesamorelin
GH-pathway option sometimes considered for abdominal fat distribution support goals in eligible adults (provider-directed).